RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867019544704319488 |
|---|---|
| author | Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia |
| author_facet | Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia |
| collection | Wiley Open Access |
| contents | RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia The Journal of Pathology AbstractInfantile fibrosarcomas (IFS) and congenital mesoblastic nephroma (CMN) are rare myofibroblastic tumors of infancy and early childhood commonly harboring the ETV6::NTRK3 gene fusion. IFS/CMN are considered as tumors with an ‘intermediate prognosis’ as they are locally aggressive, but rarely metastasize, and generally have a favorable outcome. A fraction of IFS/CMN‐related neoplasms are negative for the ETV6::NTRK3 gene rearrangement and are characterized by other chimeric proteins promoting MAPK signaling upregulation. In a large proportion of these tumors, which are classified as IFS‐like mesenchymal neoplasms, the contributing molecular events remain to be identified. Here, we report three distinct rearrangements involving RAF1 among eight ETV6::NTRK3 gene fusion‐negative tumors with an original histological diagnosis of IFS/CMN. The three fusion proteins retain the entire catalytic domain of the kinase. Two chimeric products, GOLGA4::RAF1 and LRRFIP2::RAF1, had previously been reported as driver events in different cancers, whereas the third, CLIP1::RAF1, represents a novel fusion protein. We demonstrate that CLIP1::RAF1 acts as a bona fide oncoprotein promoting cell proliferation and migration through constitutive upregulation of MAPK signaling. We show that the CLIP1::RAF1 hyperactive behavior does not require RAS activation and is mediated by constitutive 14‐3‐3 protein‐independent dimerization of the chimeric protein. As previously reported for the ETV6::NTRK3 fusion protein, CLIP1::RAF1 similarly upregulates PI3K‐AKT signaling. Our findings document that RAF1 gene rearrangements represent a recurrent event in ETV6::NTRK3‐negative IFS/CMN and provide a rationale for the use of inhibitors directed to suppress MAPK and PI3K‐AKT signaling in these cancers. © 2024 The Pathological Society of Great Britain and Ireland. 10.1002/path.6272 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/path.6272 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_6272 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia The Journal of Pathology RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors Marialetizia Motta Sabina Barresi Simone Pizzi Delfina Bifano Jennifer Lopez Marti Marta Garrido‐Pontnou Elisabetta Flex Alessandro Bruselles Isabella Giovannoni Giovannina Rotundo Alessandra Fragale Valentina Tirelli Silvia Vallese Andrea Ciolfi Gianni Bisogno Rita Alaggio Marco Tartaglia The Journal of Pathology AbstractInfantile fibrosarcomas (IFS) and congenital mesoblastic nephroma (CMN) are rare myofibroblastic tumors of infancy and early childhood commonly harboring the ETV6::NTRK3 gene fusion. IFS/CMN are considered as tumors with an ‘intermediate prognosis’ as they are locally aggressive, but rarely metastasize, and generally have a favorable outcome. A fraction of IFS/CMN‐related neoplasms are negative for the ETV6::NTRK3 gene rearrangement and are characterized by other chimeric proteins promoting MAPK signaling upregulation. In a large proportion of these tumors, which are classified as IFS‐like mesenchymal neoplasms, the contributing molecular events remain to be identified. Here, we report three distinct rearrangements involving RAF1 among eight ETV6::NTRK3 gene fusion‐negative tumors with an original histological diagnosis of IFS/CMN. The three fusion proteins retain the entire catalytic domain of the kinase. Two chimeric products, GOLGA4::RAF1 and LRRFIP2::RAF1, had previously been reported as driver events in different cancers, whereas the third, CLIP1::RAF1, represents a novel fusion protein. We demonstrate that CLIP1::RAF1 acts as a bona fide oncoprotein promoting cell proliferation and migration through constitutive upregulation of MAPK signaling. We show that the CLIP1::RAF1 hyperactive behavior does not require RAS activation and is mediated by constitutive 14‐3‐3 protein‐independent dimerization of the chimeric protein. As previously reported for the ETV6::NTRK3 fusion protein, CLIP1::RAF1 similarly upregulates PI3K‐AKT signaling. Our findings document that RAF1 gene rearrangements represent a recurrent event in ETV6::NTRK3‐negative IFS/CMN and provide a rationale for the use of inhibitors directed to suppress MAPK and PI3K‐AKT signaling in these cancers. © 2024 The Pathological Society of Great Britain and Ireland. 10.1002/path.6272 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6272 |